Di Francia R - Search Results

1

Antioxidant diet and genotyping as tools for the prevention of liver disease.

Di Francia R, Rinaldi L, Cillo M, Varriale E, Facchini G, D'Aniello C, Marotta G, Berretta M. Di Francia R, et al. Eur Rev Med Pharmacol Sci. 2016 Dec;20(24):5155-5163. Eur Rev Med Pharmacol Sci. 2016. PMID: 28051253 Free article. Review.

2

Decision criteria for rational selection of homogeneous genotyping platforms for pharmacogenomics testing in clinical diagnostics.

Di Francia R, Frigeri F, Berretta M, Cecchin E, Orlando C, Pinto A, Pinzani P. Di Francia R, et al. Clin Chem Lab Med. 2010 Apr;48(4):447-59. doi: 10.1515/CCLM.2010.112. Clin Chem Lab Med. 2010. PMID: 20192881 Review.

3

Molecular diagnostics for pharmacogenomic testing of fluoropyrimidine based-therapy: costs, methods and applications.

Di Francia R, Berretta M, Catapano O, Canzoniero LM, Formisano L. Di Francia R, et al. Clin Chem Lab Med. 2011 Jul;49(7):1105-11. doi: 10.1515/CCLM.2011.181. Epub 2011 Apr 20. Clin Chem Lab Med. 2011. PMID: 21504372 Review.

4

Genetic variants influencing fluoropyrimidine based-therapy and available methods to detect them.

Di Francia R, Cimino L, Berretta M. Di Francia R, et al. Eur Rev Med Pharmacol Sci. 2012 Mar;16(3):285-98. Eur Rev Med Pharmacol Sci. 2012. PMID: 22530343 Review.

5

Knowledge and skills needs for health professions about pharmacogenomics testing field.

Di Francia R, Valente D, Catapano O, Rupolo M, Tirelli U, Berretta M. Di Francia R, et al. Eur Rev Med Pharmacol Sci. 2012 Jun;16(6):781-8. Eur Rev Med Pharmacol Sci. 2012. PMID: 22913211 Review.

6

Pharmacogenomics panel test for prevention toxicity in patient who receive Fluoropirimidine/Oxaliplatin-based therapy.

Di Francia R, Siesto RS, Valente D, Spart D, Berretta M. Di Francia R, et al. Eur Rev Med Pharmacol Sci. 2012 Sep;16(9):1211-7. Eur Rev Med Pharmacol Sci. 2012. PMID: 23047504 Free article. Review.

7

Antiblastic treatment, for solid tumors, during pregnancy: a crucial decision.

Berretta M, Di Francia R, Lleshi A, De Paoli P, Li Volti G, Bearz A, Del Pup L, Tirelli U, Michieli M. Berretta M, et al. Among authors: di francia r. Int J Immunopathol Pharmacol. 2012 Apr-Jun;25(2 Suppl):1S-19S. doi: 10.1177/03946320120250s201. Int J Immunopathol Pharmacol. 2012. PMID: 23092516 Free article. Review.

8

Nutrition in oncologic patients during antiblastic treatment.

Berretta M, Michieli M, Di Francia R, Cappellani A, Rupolo M, Galvano F, Fisichella R, Berretta S, Tirelli U. Berretta M, et al. Among authors: di francia r. Front Biosci (Landmark Ed). 2013 Jan 1;18(1):120-32. doi: 10.2741/4091. Front Biosci (Landmark Ed). 2013. PMID: 23276913 Free article. Review.

9

Current strategies to minimize toxicity of oxaliplatin: selection of pharmacogenomic panel tests.

Di Francia R, Siesto RS, Valente D, Del Buono A, Pugliese S, Cecere S, Cavaliere C, Nasti G, Facchini G, Berretta M. Di Francia R, et al. Anticancer Drugs. 2013 Nov;24(10):1069-78. doi: 10.1097/CAD.0000000000000002. Anticancer Drugs. 2013. PMID: 24025562 Review.

10

Promestriene, a specific topic estrogen. Review of 40 years of vaginal atrophy treatment: is it safe even in cancer patients?

Del Pup L, Di Francia R, Cavaliere C, Facchini G, Giorda G, De Paoli P, Berretta M. Del Pup L, et al. Among authors: di francia r. Anticancer Drugs. 2013 Nov;24(10):989-98. doi: 10.1097/CAD.0b013e328365288e. Anticancer Drugs. 2013. PMID: 24080714 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

92 results

Search Page

Filters